机译:The safety and clinical effectiveness of rapid infusion with CT‐P10 in patients with non‐Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non‐interventional post‐authorization safety study in Europe
U.O.C Ematologia, Azienda Ospedaliero‐Universitaria Senese ‐ Policlinico Santa Maria alle Scotte;
Celltrion Healthcare Co. Ltd.;
IRCCS Azienda Ospedaliero‐Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”Nottingham City Hospital,Nottingham University Hospitals NHS TrustSunderland Royal Hospital,South Tyneside and Sunderland NHS Foundation TrustCentre Hospitalier Lyon Sud ‐ Service d’Hématologie CliniqueHematology Department,ASST Spedali Civili di BresciaHematology Department,Hospital Universitario Virgen de la MacarenaThe Royal Marsden NHS Foundation TrustHematology Department,Hospital Morales Meseguer de Murcia;
biosimilar pharmaceuticals; chronic; infusion; intravenous; lymphocytic leukemia; lymphoma; non‐Hodgkin; rituximab;